Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

September 9, 2025 by Alan Khadavi

New Treatments for Eosinophilic Esophagitis (EoE)

new treatments for eosinophilic esophagitis

New treatments for eosinophilic esophagitis are on the horizon. Eosinophilic esophagitis remains a challenging chronic inflammatory condition with limited therapeutic options. While dietary modifications, proton-pump inhibitors, and topical corticosteroids remain mainstays—and with the 2024 FDA approval of Eohilia (budesonide oral suspension) offering the only oral option—many patients still experience persistent symptoms or seek alternatives with […]

Filed Under: Blog, eosinophilic esophagitis

March 15, 2025 by Alan Khadavi

One food elimination diet in eosinophilic esophagitis

one food elimination diet

Comparing the One-Food Elimination Diet and Four-Food Elimination Diets in Eosinophilic Esophagitis: Eosinophilic esophagitis (EoE) is a chronic, immune-mediated esophageal disorder triggered by food allergens. Dietary management is a cornerstone of treatment, with elimination diets being widely used. The one-food elimination diet (1-FED) and four-food elimination diet (4-FED) are two commonly utilized strategies. This review […]

Filed Under: Blog, eosinophilic esophagitis

December 3, 2020 by Alan Khadavi

Eohilia Budesonide Oral Suspension for Eosinophilic Esophagitis

eohilia

Eohilia, a budesonide oral suspension is set to be the first FDA approved treatment for eosninophilic esophagitis. Takeda pharmaceuticals is the manufacturer of the drug. Eosinophilic esophagitis (EoE) is a chronic, immune-mediated, inflammatory disease localized in the esophagus. The prevalence of EoE is rising. Approximately 1 in 2000 people in the US live with EoE.  […]

Filed Under: Blog, eosinophilic esophagitis

March 26, 2020 by Alan Khadavi

Future Eosinophilic Esophagitis Treatment Options

eosinophilic esophagitis treatment

Future eosinophilic esophagitis treatments are currently in development.  There are currently on FDA approved medications for the treatment of EoE.  Commonly used treatments now are proton pump inhibitors, swallowed or topical corticosteroids and food elimination diets.  Although each of these options is effective, there are limitations.  Swallowed steroids can control inflammation 70-80% of the time, […]

Filed Under: biologics, Blog, eosinophilic esophagitis

February 6, 2020 by Alan Khadavi

Eosinophilic Esophagitis (EoE) Treatment

eohilia

Eosinophilic esophagitis (EoE) is an eosinophilic rich gastrointestinal/allergy disease increasing in pediatrics and adults worldwide.  The diagnosis requires greater than or equal to 15 eosinophils per high-power field on light microscopy after a biopsy.  Symptoms reflect esophageal dysfunction, and typical endoscopic features include linear furrows, white plaques, and concentric rings. Progressive disease leads to tissue […]

Filed Under: Blog, eosinophilic esophagitis

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page